Neuronetics Coverage Started with Buy Rating by B. Riley

B. Riley has begun coverage of Neuronetics, giving the stock a buy rating. This move signals positive expectations for Neuronetics' market performance. The article does not provide specific numbers on the stock's current price or projected targets. For investors, a buy rating typically indicates analyst confidence and could suggest potential appreciation in stock value for Neuronetics (STIM).